STOCK TITAN

Incyte to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Incyte announced its participation in several investor conferences throughout June 2021. Key events include the William Blair 41st Annual Growth Stock Conference on June 3, the BioPharma Sustainability Roundtable’s CEO Investor Forum on June 7, the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, and Guggenheim’s series on June 28. These presentations will be available for live webcast and replay at Investor.Incyte.com.

Incyte is a biopharmaceutical company focused on addressing unmet medical needs through innovative therapeutics.

Positive
  • None.
Negative
  • None.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

  • William Blair 41st Annual Growth Stock Conference (Virtual) on Thursday, June 3, 2021 at 1:00 pm (EDT)
  • BioPharma Sustainability Roundtable’s CEO Investor Forum on Monday, June 7, 2021 at 1:35 pm (EDT)
  • Goldman Sachs 42nd Annual Global Healthcare Conference (Virtual) on Tuesday, June 8, 2021 at 8:00 am (EDT)
  • Guggenheim’s “Biopharma’s Next Decade: Views from the Top on Global Strategy and Innovation” Series on Monday, June 28, 2021 at 11:00 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

FAQ

When is Incyte presenting at the William Blair Growth Stock Conference?

Incyte will present at the William Blair 41st Annual Growth Stock Conference on June 3, 2021, at 1:00 pm EDT.

What are the key dates for Incyte's investor conferences in June 2021?

Incyte's key conference dates are June 3 (William Blair), June 7 (BioPharma Sustainability Roundtable), June 8 (Goldman Sachs), and June 28 (Guggenheim).

Is there a webcast available for Incyte's June presentations?

Yes, Incyte's presentations will be webcast live and available for replay at Investor.Incyte.com.

What is the focus of Incyte as a biopharmaceutical company?

Incyte focuses on finding solutions for serious unmet medical needs through the development of proprietary therapeutics.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON